For the differentiation of monocytes from MS patients, we used M-CSF because both of the CSF1 receptor ligands, M-CSF and IL-34, are expressed in the brain (55), and CSF1R signaling is necessary for the maintenance of microglia (56). This evidence concerns the gene CSF1 and myeloid sarcoma.